Gender and anti-thrombotic therapy: from biology to clinical implications.

about

Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy.

P2860

Q30278548-9766496E-EF68-47CD-8DC1-4F2739C98135 Q48689443-852C010A-52E7-4803-B6DE-8F9439819246

P2860

Gender and anti-thrombotic therapy: from biology to clinical implications.

Item

http://www.wikidata.org/entity/Q38182428

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Gender and anti-thrombotic therapy: from biology to clinical implications.

@en

type

Item

label

Gender and anti-thrombotic therapy: from biology to clinical implications.

@en

prefLabel

Gender and anti-thrombotic therapy: from biology to clinical implications.

@en

P1476

Gender and anti-thrombotic therapy: from biology to clinical implications.

@en

P2093

Cinzia Fatini

http://www.w3.org/2001/XMLSchema#string

Gabriele Cioni

http://www.w3.org/2001/XMLSchema#string

Lorenza Rossi

http://www.w3.org/2001/XMLSchema#string

Maddalena Pazzi

http://www.w3.org/2001/XMLSchema#string

Rosanna Abbate

http://www.w3.org/2001/XMLSchema#string

P2860

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Platelets of female mice are intrinsically more sensitive to agonists than are platelets of males

Low-dose aspirin increases aspirin resistance in patients with coronary artery disease

Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases

Low-dose aspirin for the prevention of atherothrombosis

Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials

Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Sex differences in platelet reactivity and response to low-dose aspirin therapy

P2888

s12265-013-9534-4

P304

72-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12265-013-9534-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Betti Giusti

Rossella Marcucci

P577

2014-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1052568822

http://www.w3.org/2001/XMLSchema#string

P698

24469554

http://www.w3.org/2001/XMLSchema#string

Gender and anti-thrombotic therapy: from biology to clinical implications.

about

P2860

P2860

Gender and anti-thrombotic therapy: from biology to clinical implications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P6179

P698